{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:49:53Z","timestamp":1789951793749,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.yebeh.2016.08.027","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T08:52:04Z","timestamp":1476435124000},"page":"200-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"PA","title":["Glutamate concentrations vary with antiepileptic drug use and mental slowing"],"prefix":"10.1016","volume":"64","author":[{"given":"Tamar M.","family":"van Veenendaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique M.","family":"IJff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert P.","family":"Aldenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.C.","family":"Lazeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas A.J.","family":"Puts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.E.","family":"Edden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.M.","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton J.A.","family":"de Louw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter H.","family":"Backes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus F.A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2016.08.027_bb0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/B978-0-444-52891-9.00073-7","article-title":"Cognitive side-effects of antiepileptic drugs","volume":"111","author":"IJff","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ane.12517","article-title":"Mental slowing in relation to epilepsy and antiepileptic medication","volume":"134","author":"Grevers","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0015","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1528-1167.2011.03325.x","article-title":"Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments","volume":"52","author":"Luoni","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-1211(00)00128-5","article-title":"The impact of epilepsy from the patient's perspective II: views about therapy and health care","volume":"41","author":"Fisher","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1755-5949.2008.00062.x","article-title":"The aspects and mechanisms of cognitive alterations in epilepsy: the role of antiepileptic medications","volume":"15","author":"Hamed","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0035","first-page":"S6","article-title":"Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects","volume":"19","author":"Sankar","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0040","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nn.3140","article-title":"A mechanism for value-guided choice based on the excitation\u2013inhibition balance in prefrontal cortex","volume":"15","author":"Jocham","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuroimage.2013.10.059","article-title":"Occipital GABA correlates with cognitive failures in daily life","volume":"87","author":"Sandberg","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nn.2559","article-title":"More GABA, less distraction: a neurochemical predictor of motor decision speed","volume":"13","author":"Sumner","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neubiorev.2015.10.004","article-title":"Metabolic and functional MR biomarkers of antiepileptic drug effectiveness: a review","volume":"59","author":"van Veenendaal","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1528-1157.2001.077889.x","article-title":"Effects of vigabatrin on brain GABA+\/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics","volume":"42","author":"Mueller","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1468-1331.2003.00506.x","article-title":"Effects of vigabatrin on brain GABA+\/Cr signals in focus-distant and focus-near brain regions monitored by 1H-NMR spectroscopy","volume":"10","author":"Mueller","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0070","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1046\/j.1471-4159.1996.67062399.x","article-title":"Human brain \u03b3-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy","volume":"67","author":"Petroff","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yebeh.2015.08.013","article-title":"Cognitive impairment in adults with epilepsy: the relationship between subjective and objective assessments of cognition","volume":"52","author":"Samarasekera","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yebeh.2009.11.024","article-title":"The cognitive impact of epileptiform EEG discharges and short epileptic seizures: relationship to characteristics of the cognitive tasks","volume":"17","author":"Aldenkamp","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0085","series-title":"Manual for Raven's progressive matrices and vocabulary scales. Section 3: the standard progressive matrices","author":"Raven","year":"2000"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnmrs.2011.06.001","article-title":"In vivo magnetic resonance spectroscopy of GABA: a methodological review","volume":"60","author":"Puts","year":"2012","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0095","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0100","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/jmri.24478","article-title":"Gannet: a batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra","volume":"40","author":"Edden","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0105","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/jmri.22520","article-title":"In vivo detection of GABA and glutamate with MEGA-PRESS: reproducibility and gender effects","volume":"33","author":"O'Gorman","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0110","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jmri.23923","article-title":"Subtraction artifacts and frequency (mis-)alignment in J-difference GABA editing","volume":"38","author":"Evans","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/mrm.25094","article-title":"Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain","volume":"73","author":"Near","year":"2015","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1109\/42.906424","article-title":"Segmentation of brain MR images through a hidden Markov random field model and the expectation\u2013maximization algorithm","volume":"20","author":"Zhang","year":"2001","journal-title":"IEEE Trans Med Imaging"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2016.08.027_bb0125","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0130","series-title":"FePsy: the iron psyche","author":"Alpherts","year":"1994"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11065-015-9295-8","article-title":"Proton magnetic resonance spectroscopy: relevance of glutamate and GABA to neuropsychology","volume":"25","author":"Ende","year":"2015","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0140","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archgenpsychiatry.2009.86","article-title":"Altered prefrontal glutamate\u2013glutamine\u2013\u03b3-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus","volume":"66","author":"Lyoo","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0145","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/mds.25010","article-title":"Brain metabolite alterations and cognitive dysfunction in early Huntington's disease","volume":"27","author":"Unschuld","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","article-title":"A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra","volume":"39","author":"Rae","year":"2014","journal-title":"Neurochem Res"},{"issue":"Suppl. 6","key":"10.1016\/j.yebeh.2016.08.027_bb0155","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/ana.10697","article-title":"Magnetic resonance spectroscopy of neurotransmitters in human brain","volume":"54","author":"Novotny","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.eplepsyres.2007.03.001","article-title":"The effect of sodium valproate on proton MRS visible neurochemical concentrations","volume":"74","author":"Simister","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00213-006-0451-y","article-title":"Topiramate raises anterior cingulate cortex glutamine levels in healthy men; a 4.0T magnetic resonance spectroscopy study","volume":"188","author":"Moore","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0170","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.pnpbp.2007.11.023","article-title":"High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam","volume":"32","author":"Pollack","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00023210-200923020-00003","article-title":"Antiepileptic drug-induced cognitive adverse effects","volume":"23","author":"Mula","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0180","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/WNL.58.3.368","article-title":"Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults","volume":"58","author":"Kuzniecky","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0185","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.neuroimage.2009.09.052","article-title":"Processing speed is correlated with cerebral health markers in the frontal lobes as quantified by neuroimaging","volume":"49","author":"Kochunov","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0190","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2007.06.027","article-title":"The relationship between white matter brain metabolites and cognition in normal aging: the GENIE study","volume":"1164","author":"Charlton","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(00)03600-X","article-title":"Neuropsychological effects of epilepsy and antiepileptic drugs","volume":"357","author":"Kwan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2016.08.027_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/08989290051137585","article-title":"Imaging cognition II: an empirical review of 275 PET and fMRI studies","volume":"12","author":"Cabeza","year":"2000","journal-title":"J Cogn Neurosci"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016304309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016304309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T18:23:01Z","timestamp":1536344581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505016304309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"alternative-id":["S1525505016304309"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.08.027","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamate concentrations vary with antiepileptic drug use and mental slowing","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}